These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18474748)

  • 1. Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis.
    Sellner J; Greeve I; Leib SL; Mattle HP
    Arch Neurol; 2008 May; 65(5):672-4. PubMed ID: 18474748
    [No Abstract]   [Full Text] [Related]  

  • 2. Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis.
    Sellner J; Greeve I; Mattle HP
    Mult Scler; 2008 Aug; 14(7):981-4. PubMed ID: 18573823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Salvatore E; Morra VB; Orefice G
    Neurology; 2009 Sep; 73(13):1078; author reply 1078-9. PubMed ID: 19786703
    [No Abstract]   [Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ
    Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
    Karabudak R; Kurne A; Guc D; Sengelen M; Canpinar H; Kansu E
    J Neurol; 2004 Mar; 251(3):279-83. PubMed ID: 15015006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis.
    Comabella M; Río J; Espejo C; Ruiz de Villa M; Al-Zayat H; Nos C; Deisenhammer F; Baranzini SE; Nonell L; López C; Julià E; Oksenberg JR; Montalban X
    Clin Immunol; 2009 Feb; 130(2):145-50. PubMed ID: 18945642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis.
    Yılmaz Ü; Gücüyener K; Atak A; Aral A; Gürkaş E; Demir E; Serdaroğlu A
    Pediatr Neurol; 2012 Sep; 47(3):171-6. PubMed ID: 22883281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Birnbaum G; Cree B; Altafullah I; Zinser M; Reder AT
    Neurology; 2008 Oct; 71(18):1390-5. PubMed ID: 18525027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Markovic-Plese S; Jewells V; Speer D
    Neurology; 2009 Jun; 72(22):1965; author reply 1965-6. PubMed ID: 19487658
    [No Abstract]   [Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis.
    Gerlach RF; Tanus-Santos JE
    Clin Neurol Neurosurg; 2006 Sep; 108(6):617-8; author reply 618. PubMed ID: 16413675
    [No Abstract]   [Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
    Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
    Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not a graves' situation.
    Ruchala M; Szczepanek E; Puszczewicz M; Sosnowski P; Sowinski J
    Am J Med; 2011 Mar; 124(3):210-4. PubMed ID: 21396501
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a.
    Pohl D; Rostasy K; Gärtner J; Hanefeld F
    Neurology; 2005 Mar; 64(5):888-90. PubMed ID: 15753430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis.
    Waubant E; Gee L; Miller K; Stabler G; Goodkin D
    J Interferon Cytokine Res; 2001 Mar; 21(3):181-5. PubMed ID: 11331041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.
    Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2004 Jun; 93(11):1417-8, A9. PubMed ID: 15165929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.
    Bernal F; Elias B; Hartung HP; Kieseier BC
    Mult Scler; 2009 Jun; 15(6):721-7. PubMed ID: 19383643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.
    Gómez-Hernández A; Sánchez-Galán E; Ortego M; Martín-Ventura JL; Blanco-Colio LM; Tarín-Vicente N; Jiménez-Nacher JJ; López-Bescos L; Egido J; Tuñón J
    Am J Cardiol; 2008 Jul; 102(1):12-8. PubMed ID: 18572029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta-1b (Extavia) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Nov; 52(1350):86-7. PubMed ID: 21045760
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon beta therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis.
    Sena A; Pedrosa R; Ferret-Sena V; Cascais MJ; Roque R; Araújo C; Couderc R
    Mult Scler; 2008 Jul; 14(6):857-9. PubMed ID: 18573825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.